drugset / Trial / NCT05283317

Effect of Mesenchymal Stromal Cells on Sepsis and Septic Shock

NCT05283317

Phase 1/2 Completed 30 enrolled TC Erciyes University
Non-randomizedParallel-groupSingle-blindTreatment

Summary

Methods:Ten patients were enrolled in the study. Adipose derived-MSCs infusions were given (1x 106/ kg, on 1st, 3rd, 5th, 7th and 9th days of therapy) together with Standard therapy. Before the MSCs applications, blood samples were collected for cytokine assessment (TNF-α, IFN-γ, IL-2, IL-4, IL-6, IL-10). The clinical and laboratory improvements were recorded and compared with control groups selected retrospectively.

Timeline

Start
2018-03-11
Primary completion
2019-08-25
Completion
2019-11-13

Drugs

EvaluationDrugModalityDoseRoute
Comparator mesenchymal stem cells Cell therapy 1e+06 cells/kg Intravenous